Functions of Human Papillomavirus Proteins

Scheffner, Martin; Romanczuk, Hannes; Münger, Karl; Huibregtse, Jon M.; Mietz, Judy A.; Howley, Peter M.

Functions of Human Papillomavirus Proteins

Files

There are no files associated with this item.

Date

1994

Authors

Scheffner, Martin

Romanczuk, Hannes

Münger, Karl

Huibregtse, Jon M.

Mietz, Judy A.

Howley, Peter M.

DOI (citable link)

10.1007/978-3-642-78487-3_5

Collections

Biologie

Publication type

Contribution to a collection

Publication status

Published

Published in

Human Pathogenic Papillomaviruses / zur Hausen, Harald (ed.). - Berlin : Springer, 1994. - (Current Topics in Microbiology and Immunology ; 186). - pp. 83-99. - ISBN 978-3-642-78489-7

Abstract

Cervical cancer is the second leading cause of deaths from cancer among women worldwide with approximately 500 000 deaths annually. Epidemiologic studies have implicated a sexually transmitted agent as a cause of cervical cancer, and molecular virology studies over the past 10 years have established a strong association between specific human papillomavirus (HPV) types and certain anogenital carcinomas, including cervical cancer (reviewed in zur Hausen and Schneider 1987). Over 65 different HPV types have now been described, and each is associated with a specific clinical entity (DeVilliers 1989). Approximately 20 or 25 HPVs have been associated with anogenital lesions; these HPVs have been further classified as either “low-risk” or “high-risk” types based on the preneoplastic character of the clinical lesions with which they are associated. Low-risk HPVs such as HPV-6 and HPV-11 are generally associated with venereal warts or condyloma acuminata which only rarely progress to malignancy. The high-risk HPVs include HPV-16 and HPV-18 and these are associated with squamous intraepithelial neoplasias which are potentially precancerous. In the cervix, they are associated with cervical intraepithelial neoplasia, or CIN. These CIN lesions are considered preneoplastic in that a small percentage of high-grade CIN lesions will progress to cervical cancer. Approximately 70% of human cervical cancers contain either HPV-16 or HPV-18 DNA (zur Hausen and Schneider 1987). Indeed, HPV-16 and HPV-18 DNA were originally isolated from human cervical carcinoma tissues (Dürst et al. 1983; Boshart et al. 1984). Other high-risk HPVs, including types 31, 33, 35, 39, 45, 51, and 52, have subsequently been identified and have also been associated with CIN lesions and with invasive cervical carcinomas. All together, approximately 85% of cervical cancers can be shown to contain DNA of one of the high-risk HPV types (Riou et al. 1990).

Subject (DDC)

570 Biosciences, Biology

Keywords

Long Control Region, Bovine Papilloma Virus, SV40 Large Tumor Antigen

Cite This

ISO 690

SCHEFFNER, Martin, Hannes ROMANCZUK, Karl MÜNGER, Jon M. HUIBREGTSE, Judy A. MIETZ, Peter M. HOWLEY, 1994. Functions of Human Papillomavirus Proteins. In: ZUR HAUSEN, Harald, ed.. Human Pathogenic Papillomaviruses. Berlin:Springer, pp. 83-99. ISBN 978-3-642-78489-7. Available under: doi: 10.1007/978-3-642-78487-3_5

BibTex

@incollection{Scheffner1994Funct-42724,
  year={1994},
  doi={10.1007/978-3-642-78487-3_5},
  title={Functions of Human Papillomavirus Proteins},
  number={186},
  isbn={978-3-642-78489-7},
  publisher={Springer},
  address={Berlin},
  series={Current Topics in Microbiology and Immunology},
  booktitle={Human Pathogenic Papillomaviruses},
  pages={83--99},
  editor={zur Hausen, Harald},
  author={Scheffner, Martin and Romanczuk, Hannes and Münger, Karl and Huibregtse, Jon M. and Mietz, Judy A. and Howley, Peter M.}
}

RDF

<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/42724">
    <dc:creator>Huibregtse, Jon M.</dc:creator>
    <dc:creator>Mietz, Judy A.</dc:creator>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:title>Functions of Human Papillomavirus Proteins</dcterms:title>
    <dc:language>eng</dc:language>
    <dc:contributor>Romanczuk, Hannes</dc:contributor>
    <dc:creator>Romanczuk, Hannes</dc:creator>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-06-27T12:49:56Z</dcterms:available>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/42724"/>
    <dc:contributor>Scheffner, Martin</dc:contributor>
    <dc:creator>Münger, Karl</dc:creator>
    <dc:creator>Scheffner, Martin</dc:creator>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-06-27T12:49:56Z</dc:date>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:contributor>Howley, Peter M.</dc:contributor>
    <dcterms:issued>1994</dcterms:issued>
    <dcterms:abstract xml:lang="eng">Cervical cancer is the second leading cause of deaths from cancer among women worldwide with approximately 500 000 deaths annually. Epidemiologic studies have implicated a sexually transmitted agent as a cause of cervical cancer, and molecular virology studies over the past 10 years have established a strong association between specific human papillomavirus (HPV) types and certain anogenital carcinomas, including cervical cancer (reviewed in zur Hausen and Schneider 1987). Over 65 different HPV types have now been described, and each is associated with a specific clinical entity (DeVilliers 1989). Approximately 20 or 25 HPVs have been associated with anogenital lesions; these HPVs have been further classified as either “low-risk” or “high-risk” types based on the preneoplastic character of the clinical lesions with which they are associated. Low-risk HPVs such as HPV-6 and HPV-11 are generally associated with venereal warts or condyloma acuminata which only rarely progress to malignancy. The high-risk HPVs include HPV-16 and HPV-18 and these are associated with squamous intraepithelial neoplasias which are potentially precancerous. In the cervix, they are associated with cervical intraepithelial neoplasia, or CIN. These CIN lesions are considered preneoplastic in that a small percentage of high-grade CIN lesions will progress to cervical cancer. Approximately 70% of human cervical cancers contain either HPV-16 or HPV-18 DNA (zur Hausen and Schneider 1987). Indeed, HPV-16 and HPV-18 DNA were originally isolated from human cervical carcinoma tissues (Dürst et al. 1983; Boshart et al. 1984). Other high-risk HPVs, including types 31, 33, 35, 39, 45, 51, and 52, have subsequently been identified and have also been associated with CIN lesions and with invasive cervical carcinomas. All together, approximately 85% of cervical cancers can be shown to contain DNA of one of the high-risk HPV types (Riou et al. 1990).</dcterms:abstract>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Howley, Peter M.</dc:creator>
    <dc:contributor>Huibregtse, Jon M.</dc:contributor>
    <dc:contributor>Mietz, Judy A.</dc:contributor>
    <dc:contributor>Münger, Karl</dc:contributor>
  </rdf:Description>
</rdf:RDF>

Bibliography of Konstanz

No